Initial Introduction of Therapy

Publishing date: 1st October 2021
Estimated time to complete: 30 minutes
Authored by Dr Mehta, this activity covers how to develop the most appropriate treatment plans, utilizing newer therapies and combinations, for recently diagnosed or referred individuals who may have a high risk of hypoglycemia.

Learning objectives

After taking part in this module, you will be able to:


In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity will be certified with 0.25 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Expiration date: 1st October 2022


Transcripts are available in French, German, Italian and Spanish.


Dr Roopa Mehta

Please login to access this content


Register for a Free Account

Scroll to Top

Dr Roopa Mehta

Metabolic Diseases Research Unit (UIEM), Department of Endocrinology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico

Roopa Mehta is an endocrinologist and researcher in the Department of Endocrinology and Metabolism at the INCMNSZ. She is the director of the lipid clinic and the cardiovascular laboratory in this hospital. She is an associate professor in both pre- and postgraduate endocrinology programs, and is a principal investigator for phase 3 clinical trials. Dr Mehta undertook her medical training at the United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals, London, UK. She subsequently trained as an endocrinologist at the INCMNSZ. On completing the residency program, Dr Mehta subspecialized in diabetes and metabolism and gained further clinical and investigative experience rotating at the Joslin Diabetes Center, Boston, MA, USA. She holds a masters degree in medical sciences from the National Autonomous University of Mexico and is currently completing her doctorate.

Dr Mehta’s research interests focus on Type 2 diabetes mellitus (clinical investigation), metabolic syndrome and dyslipidemia. She has received the Alfonso Rivera Research Award and the Young Investigator Award from the AACE. Dr Mehta has authored and co-authored publications in international journals in addition to numerous book chapters. She is a co-editor of a book for patients – “Living with Diabetes: A Practical Manual”. 


Roopa Mehta declares honoraria and/or consultation fees from Novo Nordisk, Abbott, AstraZeneca, Amgen, Boehringer Ingelheim, Eli Lilly, Sanofi, and Janssen.



  • This field is for validation purposes and should be left unchanged.

Contact us

  • This field is for validation purposes and should be left unchanged.

Sign up

* indicates required